Stay updated with breaking news from Nasdaq Tcon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts at StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) in a research report issued on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price target on shares of TRACON Pharmaceuticals in a research note […]
StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $7.00 target price on shares of TRACON Pharmaceuticals in a report on Monday, […]
StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 target price on shares of TRACON Pharmaceuticals in a research note […]
StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 price target on shares of TRACON Pharmaceuticals in a research report […]
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report report published on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price target on shares of TRACON Pharmaceuticals in a report on Monday, November […]